VALLEY FORGE, Pa.--(BUSINESS WIRE)--Sept. 7,
2005--AmerisourceBergen Corporation (NYSE:ABC) today announced its
intention to issue under Rule 144A and Regulation S $500 million
senior notes due 2015 and $400 million senior notes due 2012. The
gross proceeds of these two transactions will be used to finance the
cash tender offer launched August 25, 2005 for AmerisourceBergen's
$500 million 8.125 percent senior notes due 2008 and its $300 million
7.25 percent senior notes due 2012; repay at maturity or, at
AmerisourceBergen's discretion, redeem any notes not tendered; and pay
related discounts, fees and expenses of these transactions. Any
remaining proceeds from the financing transactions are intended to be
used for general corporate purposes.
This announcement is not an offer to sell nor a solicitation of an
offer to buy the securities described herein. AmerisourceBergen is
offering the Notes in reliance upon exemptions from registration under
the Securities Act of 1933, as amended, for offers and sales of
securities that do not involve a public offering. The securities to be
offered have not been and will not be registered under the Securities
Act of 1933, as amended, or any state securities laws and may not be
offered or sold in the United States absent registration or a
applicable exemption from registration requirements.
About AmerisourceBergen
AmerisourceBergen (NYSE:ABC) is one of the largest pharmaceutical
services companies in the United States. Servicing both pharmaceutical
manufacturers and healthcare providers in the pharmaceutical supply
channel, the Company provides drug distribution and related services
designed to reduce costs and improve patient outcomes.
AmerisourceBergen's service solutions range from pharmacy automation,
bedside medication safety systems, and pharmaceutical packaging to
pharmacy services for skilled nursing and assisted living facilities,
reimbursement and pharmaceutical consulting services, and physician
education. With more than $54 billion in revenue, AmerisourceBergen is
headquartered in Valley Forge, PA, and employs more than 14,000
people. AmerisourceBergen is ranked #23 on the Fortune 500 list. For
more information, go to www.amerisourcebergen.com.
FORWARD-LOOKING STATEMENTS
This news release may contain certain "forward-looking statements"
within the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934. These statements
are based on management's current expectations and are subject to
uncertainty and changes in circumstances. Actual results may vary
materially from the expectations contained in the forward-looking
statements. Forward-looking statements may include statements
addressing AmerisourceBergen's future financial and operating results
and the benefits, efficiencies and savings to be derived from the
Company's integration plans to consolidate its distribution network.
The following factors, among others, could cause actual results to
differ materially from those described in any forward-looking
statements: competitive pressures; the loss of one or more key
customer or supplier relationships; customer defaults or insolvencies;
changes in customer mix; supplier defaults or insolvencies; changes in
pharmaceutical manufacturers' pricing and distribution policies or
practices; adverse resolution of any contract or other disputes with
customers (including departments and agencies of the U.S. Government)
or suppliers; regulatory changes; changes in U.S. government policies
(including reimbursement; changes arising from the Medicare
Modernization Act); market interest rates; operational or control
issues arising from AmerisourceBergen's outsourcing of information
technology activities; success of the Pharmaceutical Distribution
segment's ability to transition its business model to fee-for-service;
success of integration, restructuring or systems initiatives;
acquisition of businesses that do not perform as we expect or that are
difficult for us to integrate or control; and other economic,
business, competitive, legal, regulatory and/or operational factors
affecting the business of AmerisourceBergen generally.
More detailed information about these and other risk factors is
set forth in AmerisourceBergen's filings with the Securities and
Exchange Commission, including its Annual Report on Form 10-K for
fiscal 2004.
AmerisourceBergen is under no obligation to (and expressly
disclaims any such obligation to) update or alter any forward -looking
statements whether as a result of new information, future events or
otherwise.
CONTACT: AmerisourceBergen Corporation, Valley Forge
Michael N. Kilpatric, 610-727-7118
[email protected]
SOURCE: AmerisourceBergen Corporation